Vascular endothelial growth factor (VEGF) is one of the critical molecular targets in cancer treatment and has been used in several successful pivotal combination regimens for not only HCC but also other cancers.16, 17, 18, 19, 20, 21, 22, 23, 24. Here, VEGFA is linked to hepatocellular carcinoma.